253 related articles for article (PubMed ID: 6368457)
1. [Recent developments in the field of fibrinolytics and anticoagulants].
Lechner K; Korninger C; Pabinger-Fasching I
Internist (Berl); 1984 Feb; 25(2):82-7. PubMed ID: 6368457
[No Abstract] [Full Text] [Related]
2. [Advantages and hazards of drug treatment in surgery. Anticoagulants and fibrinolytic agents].
Gross R
Chirurg; 1968 May; 39(5):201-8. PubMed ID: 4974339
[No Abstract] [Full Text] [Related]
3. [Advances in the treatment and prevention of thromboembolism].
Sas G
Orv Hetil; 1988 Mar; 129(12):591-9. PubMed ID: 3283645
[No Abstract] [Full Text] [Related]
4. [Hypercoagulation and cancer. New treatment possibilities].
Lykke J; Nielsen HJ
Ugeskr Laeger; 2004 Aug; 166(33):2781-4. PubMed ID: 15344855
[No Abstract] [Full Text] [Related]
5. The status of new anticoagulants.
Bates SM; Weitz JI
Br J Haematol; 2006 Jul; 134(1):3-19. PubMed ID: 16803562
[TBL] [Abstract][Full Text] [Related]
6. [Therapy and prevention of thromboembolic diseases: anticoagulants and fibrinolytics].
Pelosio L; Marasco A; Puopolo G
Clin Ter; 1982 Feb; 100(4):417-25. PubMed ID: 7044661
[No Abstract] [Full Text] [Related]
7. Future of anticoagulant therapy.
Harenberg J; Wehling M
Cardiovasc Ther; 2011 Oct; 29(5):291-300. PubMed ID: 20626401
[TBL] [Abstract][Full Text] [Related]
8. [Anticoagulants].
Coelho E
Rev Hosp Clin Fac Med Sao Paulo; 1968 Jul; 23(4):217-28. PubMed ID: 4175980
[No Abstract] [Full Text] [Related]
9. [Low-molecular-weight heparin - enoxaparin (clexane) in the prevention of thromboembolic complications in surgical patients].
Zabolotskikh IB; Sin'kov SV; Klevko VA
Anesteziol Reanimatol; 2001; (2):70-5. PubMed ID: 11494909
[No Abstract] [Full Text] [Related]
10. Anticoagulation recidivans.
N Engl J Med; 1968 May; 278(22):1231-2. PubMed ID: 5647745
[No Abstract] [Full Text] [Related]
11. [Prevention of postoperative thromboembolic complications (a review of the literature)].
Pavlovskiĭ DP; Baluda VP; Sushkevich GN
Khirurgiia (Mosk); 1977 May; (5):124-30. PubMed ID: 325273
[No Abstract] [Full Text] [Related]
12. [Therapeutic fibrinolysis].
Straub PW
Schweiz Med Wochenschr; 1973 May; 103(20):753-7. PubMed ID: 4702993
[No Abstract] [Full Text] [Related]
13. Implications of anticoagulant therapy.
Ellison N; Jobes DR; Schwartz AJ
Int Anesthesiol Clin; 1982; 20(4):121-35. PubMed ID: 6757142
[No Abstract] [Full Text] [Related]
14. [Heparins, antivitamins K. Principles and rules of use. Posology of non-fractionated heparins].
Delsart D; Chambefort V; Decousus H
Rev Prat; 2001 Sep; 51(13):1489-97. PubMed ID: 11601082
[No Abstract] [Full Text] [Related]
15. Antithrombotic therapy: the expanding role of low molecular weight heparin.
Turpie AG
Indian Heart J; 1997; 49(5):489-92. PubMed ID: 9505014
[No Abstract] [Full Text] [Related]
16. Antithrombotic therapy for venous thromboembolic disease.
Hyers TM; Hull RD; Weg JG
Chest; 1989 Feb; 95(2 Suppl):37S-51S. PubMed ID: 2644102
[No Abstract] [Full Text] [Related]
17. [Conventional or low molecular weight heparin in the treatment of venous thromboembolic disease?].
Ruiz Manzano J; Monreal M
Med Clin (Barc); 1998 Nov; 111(18):697-9. PubMed ID: 9887434
[No Abstract] [Full Text] [Related]
18. [Anticoagulant therapy. Practical recommendations for its use].
Iturbe Alessio I; Fabrega Ramírez JR
Arch Inst Cardiol Mex; 1984; 54(3):293-6. PubMed ID: 6466001
[No Abstract] [Full Text] [Related]
19. Heparin therapy: current regimens and principles of monitoring.
Berry BR; Nantel S
Postgrad Med; 1996 Jun; 99(6):64-6, 69-76. PubMed ID: 8668639
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of thromboembolic conditions with thrombolytics and anticoagulants].
Wojczuk J
Wiad Lek; 1974 May; 27(10):877-82. PubMed ID: 4134634
[No Abstract] [Full Text] [Related]
[Next] [New Search]
